Takeda Revamp to Cut Costs, Use AI to Incur ¥150 Billion Charge
Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next…
Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year starting next…
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026. Takeda Pharmaceutical Company Limited…
Takeda Pharmaceutical Co. has struck a deal with China’s Innovent Biologics Inc. to co-develop cancer therapies, underscoring a surge of…
Lottie Woad shot a level-par first round to lie five shots off the AIG Women’s Open lead jointly held by…